Baduanjin and Neuromodulation for Knee Osteoarthritis
This study is looking into how Baduanjin (BDJ), a mind-body exercise, combined with tDCS (a brain stimulation method), might help people with knee osteoarthritis. Researchers want to understand the brain changes that happen with these exercises. You might be able to join if you are 45-75 years old, have knee osteoarthritis for at least three months, and can participate in BDJ and stretching programs. The main goal is to see how brain activity (resting state functional connectivity) changes after 12 weeks of treatment. The current recruitment status is unclear.
- Study design
- This interventional study plans to enroll 140 participants. It will compare the effects of BDJ, tDCS, sham tDCS, and exercise.
- What's involved
- You would participate in a 12-week study involving BDJ and stretching programs, and undergo MRI scans.
- Compensation
- Not stated in the trial record.
- Follow-up
- Brain activity will be measured at baseline and after 12 weeks of treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA
At a glance
Conditions
NCT05839535
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Massachusetts General Hospital
Charlestown, Massachusettsstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- M1 resting state functional connectivityBaseline, post-treatment (12 weeks)
Changes in brain resting-state connectivity between the primary motor cortex (M1) and other brain regions pre- and post-treatments, analyzed using the CONN Toolbox (https://web.conn-toolbox.org/)